SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

                       Pursuant to Section 13 or 15(d) of
                       The Securities Exchange Act of 1934

                        Date of Report: February 22, 2007

                                   XSUNX, INC.
                                 ---------------
             (Exact name of registrant as specified in its charter)



 Colorado                   000-29621                   84-1384159
 --------                   ---------                   ----------
(State or other             (Commission               (IRS Employer
jurisdiction of             File Number)            Identification No.)
 incorporation)


                      65 Enterprise, Aliso Viejo, CA 92656
                      ------------------------------------
             (New address of principal executive offices) (Zip Code)

       Registrant's telephone number, including area code: (949) 330-8060

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):

      |_|   Written communications pursuant to Rule 425 under the Securities Act
            (17 CFR 230.425)

      |_|   Soliciting material pursuant to Rule 14a-12 under the Exchange Act
            (17 CFR 240.14a-12)

      |_|   Pre-commencement communications pursuant to Rule 14d-2(b) under the
            Exchange Act (17 CFR 240.14d-2(b))

      |_|   Pre-commencement communications pursuant to Rule 13e-4(c) under the
            Exchange Act (17 CFR 240.13e-4(c))






                SECTION 1 - REGISTRANT'S BUSINESS AND OPERATIONS


Item 1.01 Entry into a Material Definitive Agreement

     The Company has entered into a Consulting  and Advisory  Agreement with Dr.
Edward Yu for two years service as a member of the Company's Scientific Advisory
Board. In conjunction with the Advisory Agreement the Company also issued to Dr.
Yu 100,000 options under the terms of a Stock Option  Agreement with an exercise
price of $.53 per share. The options carry a 5 year exercise term and vest under
the following provisions:

        (a)    The  Option  shall  become  exercisable  in the  amount of 12,500
               shares upon the First  Vesting Date of May 23, 2007.  Thereafter,
               the Option  shall vest become  exercisable  at the rate of 12,500
               Shares per calendar quarter,  or any apportioned  amount thereof,
               during the term of engagement by XsunX, Inc. of the Optionee.


                 SECTION 9 - FINANCIAL STATEMENTS AND EXHIBITS

Item 9.01 Financial Statements and Exhibits

        A.  Financial Statements - none

        B.  Exhibits -  10.1 Consulting Advisory Agreement(Dr. Edward Yu)
                        10.2 Stock Option Agreement (Dr. Edward Yu)







                                   SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.

Date: February 27, 2007

                                           XSUNX, INC.



                                           By: /s/ Tom Djokovich
                                               -----------------------------
                                               Tom Djokovich, CEO/President